JPY 1090.0
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 490.46 Million JPY | 49.74% |
2022 | 327.53 Million JPY | -23.46% |
2021 | 427.93 Million JPY | 31.87% |
2020 | 324.5 Million JPY | -10.11% |
2019 | 361 Million JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 206 Million JPY | -5.96% |
2023 Q2 | 97.36 Million JPY | 44.42% |
2023 Q4 | 219.04 Million JPY | 105.44% |
2023 Q3 | 106.62 Million JPY | 9.51% |
2023 FY | 490.46 Million JPY | 49.74% |
2023 Q1 | 67.42 Million JPY | -57.93% |
2022 Q3 | 79 Million JPY | 33.2% |
2022 FY | 327.53 Million JPY | -23.46% |
2022 Q4 | 160.24 Million JPY | 102.84% |
2022 Q2 | 59.3 Million JPY | 0.0% |
2021 FY | 427.93 Million JPY | 31.87% |
2020 FY | 324.5 Million JPY | -10.11% |
2019 FY | 361 Million JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 26.45 Billion JPY | 98.146% |
Cosmo Bio Company,Limited | 9.34 Billion JPY | 94.749% |
H.U. Group Holdings, Inc. | 236.95 Billion JPY | 99.793% |
FALCO HOLDINGS Co., Ltd. | 43 Billion JPY | 98.86% |
BML, Inc. | 137.96 Billion JPY | 99.645% |
Human Metabolome Technologies, Inc. | 1.34 Billion JPY | 63.553% |
Precision System Science Co., Ltd. | 3.97 Billion JPY | 87.677% |